Last quarter (Q3 2023), Roivant Sciences's total revenue was $37.14M, an increase of 117.80% from the same quarter last year. In Q3, Roivant Sciences's net income was $5.10B. See Roivant Sciences’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Mar 23	Mar 22	Mar 21
Total Revenue	$ 90.90M	$ 33.27M	$ 55.29M	$ 23.80M
Cost of Revenue	-	-	-	$ 2.06M
Gross Profit	$ 95.86M	$ 61.28M	$ 55.29M	$ 21.74M
Operating Expense	$ 936.26M	$ 1.24B	$ 1.41B	$ 496.50M
Operating Income	$ 4.54B	$ -1.18B	$ -1.35B	$ -474.77M
Net Non Operating Interest Income Expense	$ -27.60M	$ -105.97M	$ -7.04M	$ -1.39M
Other Income Expense	$ 13.12M	$ -24.27M	$ -431.21M	$ -422.39M
Pretax Income	$ 4.44B	$ -1.22B	$ -923.75M	$ -898.55M
Tax Provision	$ 31.18M	$ 5.19M	$ 369.00K	$ 1.69M
Earnings From Equity Interest Net Of Tax	-	-	-	-
Net Income Common Stockholders	$ 4.54B	$ -1.01B	$ -845.26M	$ -809.23M
Basic EPS	$ 5.59	$ -2.84	$ -2.52	$ -1.18
Diluted EPS	$ 5.25	$ -2.84	$ -2.52	$ -1.18
Basic Average Shares	$ 2.33B	$ 712.79M	$ 669.75M	$ 684.79M
Diluted Average Shares	$ 2.37B	$ 712.79M	$ 669.75M	$ 684.79M
Dividend Per Share	-	-	-	-
Total Operating Income As Reported	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-
Rent Expense Supplemental	-	-	-	-
Total Expenses	$ 936.26M	$ 1.24B	$ 1.41B	$ 498.56M
Net Income From Continuing And Discontinued Operation	$ 4.50B	$ -1.23B	$ -845.26M	$ -809.23M
Normalized Income	$ 4.38B	-	-	$ -497.19M
Interest Expense	-	-	-	$ 2.81M
EBIT	$ 4.47B	$ -1.20B	$ -916.71M	$ -895.74M
EBITDA	$ 4.49B	$ -1.17B	$ -903.50M	$ -895.74M

Currency in USD

Roivant Sciences Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing